Engineering Cells for Biomedical Applications

The National Cancer Institute (NCI) Division of Cancer Treatment and Diagnosis invites you to join the Technology Development Seminar Series with Dr. Quanyin Hu on November 4, 2026, from 11:00 am-12:00 pm ET. 

Speaker selected by the Developmental Therapeutics Program. 

Advance registration is required. Register here 

As important biological entities and natural carriers for proteins and molecules, endogenous cells with low immunogenicity and toxicity have attracted considerable attention for biomedical applications and have achieved encouraging progress, especially as therapeutics and delivery carriers. The convergence of multiple disciplines has equipped cell engineering with control over their spatiotemporal distribution to enhance treatment efficacy and reduce side effects. In this talk, Dr. Quanyin Hu will introduce his group’s ongoing efforts in engineering endogenous cells for various biomedical applications with a particular focus on cancer immunotherapy. 

Dr. Quanyin Hu is an Associate Professor and Joseph R. and Bonna A. Robinson Distinguished Chair, at the School of Pharmacy, University of Wisconsin-Madison (UW-Madison). He received his Ph. D. degree in Biomedical Engineering at the University of North Carolina at Chapel Hill and North Carolina State University from 2014-2018. Before he joined UW-Madison, he was a postdoc associate at the Koch Institute for Integrative Cancer Research at the Massachusetts Institute of Technology from 2018-2020. Dr. Hu is an elected AIMBE fellow and currently serving as the Deputy Editor for the Journal of Nanobiotechnology. He has published more than 100 research papers, including in Nature Biotechnology (2026, 2024), Nature Nanotechnology (2025), Science Translational Medicine (2022), and Nature Biomedical Engineering (2021, 2018), with over 20,000 citations. Dr. Hu is recognized as an NCI R01 awardee, NIBIB R01 awardee, American Cancer Society Research Scholar, V Foundation Scholar, MIT Technology Review’s Innovator under 35 (TR35) China (2022), AAPS Emerging Leader (2026), Materials Today Rising Star (2026), the 2023 BMES-CMBE Rising Star Junior Faculty, 2023 Journal of Nanobiotechnology Rising Star, 2022 iCANX Young Scientist, UW Madison Early Career Innovator, Clarivate Highly Cited Researcher (2022-2026), a Young Investigator from many societies and Foundations, and an Emerging Investigator from many journals. 

Read about past presenters and view available recordings for select seminars here. 

Contact Jung S. Byun, PhD, MPH for more information.